In systemic sclerosis (SSc; scleroderma) fibrosis of the skin can lead to considerable
morbidity. No significant improvement has been reported from studies investigating …

Systemic scleroderma—also known as systemic sclerosis (SS c)—is a chronic systemic
connective tissue disease characterized by collagen deposition in cutaneous and internal …

Systemic and localized scleroderma are difficult to manage diseases with no accepted gold
standard of therapy to date. Phototherapeutic modalities for scleroderma show promise. A …

Scleroderma is a chronic disease of connective tissue characterized by deposition of large
amounts of collagen. Localized scleroderma affects only the skin, whereas systemic …

Phototherapy is an effective treatment strategy for a variety of sclerosing skin conditions.
There are a number of phototherapeutic modalities used for the treatment of sclerosing skin …

The treatment of sclerosing skin diseases [systemic sclerosis, localized scleroderma, lichen
sclerosus et atrophicus, sclerodermoid graft‐vs.‐host disease, scleredema adultorum …

Summary Background Ultraviolet (UV) A1 phototherapy is an effective anti‐inflammatory
treatment modality that influences fibroblast functions. Objectives To document the effects of …

Until recently, various therapies for localized scleroderma have been used with limited
success. Recently, phototherapy, with or without psoralen, was proposed as a successful …

Background Localized scleroderma (LS) comprises a spectrum of sclerotic autoimmune
diseases primarily affecting the dermis. Various treatment modalities have been …

Background. The cutaneous changes seen in systemic sclerosis (SSc) can result in
considerable patient morbidity. Aim. We previously reported on the beneficial effect of …